The MedPacto Inc. board has appointed Dr. Seong-Jin Kim as a co-chief executive officer
Aug 25, 2016PRESS RELEASESHit 397
The founder of MedPacto, Inc. Dr. Seong-Jin Kim became a co-chief executive officer. He is also a major share holder.
|Previous||Collaboration with ANRT|
|Next||MedPacto Announces Clinical Collaboration with MSD to Evaluate Vactosertib, an Investigational TGF-β Type I Receptor Inhibitor, in combination with KEYTRUDA® (pembrolizumab)|